Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.

about

Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland.

P2860

Q39583831-6E484446-6083-42AC-9490-CE81F6D5B440

P2860

Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.

Item

http://www.wikidata.org/entity/Q41076505

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Novel quality indicators for m ...... reatment centers in Australia.

@en

type

Item

label

Novel quality indicators for m ...... reatment centers in Australia.

@en

prefLabel

Novel quality indicators for m ...... reatment centers in Australia.

@en

P1476

Novel quality indicators for m ...... treatment centers in Australia

@en

P2093

Allan Zimet

http://www.w3.org/2001/XMLSchema#string

Ben Tran

http://www.w3.org/2001/XMLSchema#string

Gary Richardson

http://www.w3.org/2001/XMLSchema#string

Hui-Li Wong

http://www.w3.org/2001/XMLSchema#string

Jeanne Tie

http://www.w3.org/2001/XMLSchema#string

Jeremy Shapiro

http://www.w3.org/2001/XMLSchema#string

Joseph McKendrick

http://www.w3.org/2001/XMLSchema#string

Kathryn Field

http://www.w3.org/2001/XMLSchema#string

Louise Nott

http://www.w3.org/2001/XMLSchema#string

Mahesh Iddawela

http://www.w3.org/2001/XMLSchema#string

P2860

Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials.

Follow-up of patients with curatively resected colorectal cancer: a practice guideline

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

Early palliative care for patients with metastatic non-small-cell lung cancer

Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable.

Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.

P304

262-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12355

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Desmond Yip

Jayesh Desai

P577

2015-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25871458

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

Australia

Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.

about

P2860

P2860

Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921